We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Chlamydia trachomatis and Cervical Squamous Cell Carcinoma—Reply

Tarja Anttila, MD; Pentti Koskela, PhD; Matti Lehtimen, MD; Joakim Dillner, MD; Jorma Paavonen, MD
JAMA. 2001;285(13):1703-1706. doi:10.1001/jama.285.13.1703.
Text Size: A A A
Published online


In Reply: The letters from Ms Gravitt and Dr Castle, and from Dr Smith and colleagues, question our finding of an association between C trachomatis infection and cervical SCC. They claim that the relatively low sensitivity of HPV serology leads to significant nondifferential misclassification bias that makes it difficult to control for residual confounding by HPV by simply adjusting for HPV seropositivity. However, it is inappropriate to compare the results of cross-sectional studies (which generally show a 99% positivity rate for HPV DNA among SCC cases) and longitudinal studies (which have found a 37% positivity rate for serum antibodies to HPV 16, 18, or 33 among women who will subsequently develop SCC). In most cases, HPV infection is usually transient. Therefore, HPV DNA positivity simply reflects the point prevalence of HPV infection, whereas HPV seropositivity is a more stable marker of past exposure to HPV. Also, recent sexual activity could increase the HPV DNA positivity among control subjects but not among those already exposed to HPV, and this could lead to significant systematic bias and hence underestimate the role of sexually transmitted cofactors. Furthermore, the association between C trachomatis and cervical carcinoma was specific for SCC but not for cervical adenocarcinoma or other noncervical anogenital carcinomas.1 Only a longitudinal approach can assess temporal association, which is critical and probably different for different microorganisms or carcinogens in general.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.